Company / SG&A Expense
Mettler Toledo SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$998.3M
FY2025
5-year range
$819.2M / $998.3M
FY2021-FY2025
Trend
+6.6%
vs FY2024
Sector context
#46 of 158
Health Care
What the data says
At $998M, Mettler Toledo's sg&a expense ranks #113 of 158 in the Health Care sector. SG&A Expense has increased for 6 consecutive years, from $795M in FY2019 to $998M in FY2025.
Based on SEC 10-K filings.
$998M in FY2025 with a 5-year CAGR of +4.2%.
Increased from $904M to $998M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +6.8%
- 5-Year CAGR
- +4.2%
- 10-Year CAGR
- -
Sector benchmark
#113 of 158 in Health CareTop 71% of 158This company $998.3M Sector average $175.9B
▼
-99.4% below sector average
Key checks
Key Insights
- Mettler Toledo's sg&a expense has grown for 6 consecutive years.
- 5-year CAGR of +4.2%, indicating consistent growth.
- In FY2025, sg&a expense increased 6.6% year-over-year.
- Ranks #46 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.22 (safe zone, above 2.9 threshold)
- Strong profit margin: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $998.3M | +6.6% |
| FY2024 | $936.3M | +3.6% |
| FY2023 | $904.1M | +10.2% |
| FY2022 | $820.2M | +0.1% |
| FY2021 | $819.2M | +0.8% |
| FY2020 | $812.8M | +2.3% |
| FY2019 | $794.9M | -2.2% |
| FY2018 | $812.8M | +2.3% |
| FY2017 | $794.9M | +6.6% |
| FY2016 | $745.4M | +6.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026